Olfatifar Meysam, Asadzadeh Aghdaei Hamid, Pourhoseingholi Mohamad Amin, Balaii Hedieh, Hashemi Nazari Saeed, Shahrokh Shabnam, Sabour Siamak, Ivanchuk Maria, Ivanchuk Pavlo, Khodakarim Soheila, Zali Mohammad Reza, Rohani Pejman, Mehralian Gholamhossein
Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Gastroenterol Hepatol Bed Bench. 2021 Fall;14(Suppl1):S66-S74.
Description of the inflammatory bowel disease natural history in Tehran province.
Inflammatory bowel disease (IBD) is a non-homogeneous disorder with an unpredictable natural history that impairs a patient's quality of life over the course of their life. As a result, providing evidence for efficient patient management is critical.
In this case series study, 198 IBD patients who were visited in our clinic at least three times routinely from Oct 2015 to May 2020 were included. Then, two panel-based approaches, the Multi-State Model (MSM) and random-effect ordered logistic, were used to deduce the clinical course of IBD, which included remission, mild, moderate to severe, and surgical states.
For ulcerative colitis (UC), women had a slightly poorer condition for remission but better for moderate to severe and a faster transition from moderate to severe to mild (HR=1.490, 95% CI: 1.02-2.16) compared to men. For Crohn's disease (CD), they had a better condition for remission but a slightly poorer condition for the severe state and higher transition from mild to moderate to severe (HR=1.221, 95% CI: 0.471-3.22) than men. Oral 5-ASA had better efficacy in people with remission and/or mild states but not for those with moderate to severe states, especially in CD (mild to moderate to serve, HR=1.526, 95% CI: 0.59-3.89). Immunosuppressive drugs were better for patients with lower disease severity, especially with UC (mild to remission, HR=1.258, 95% CI: 0.75-2.09).
Panel approaches have the potential efficacy to tackle the unpredictable clinical course of IBD (UC/CD). Hence, we highly recommend that our findings be included into the Iranian routine clinical environment of IBD and/or that related studies be conducted in Iran and other regions to gain a better understanding of the natural history of IBD.
描述德黑兰省炎症性肠病的自然史。
炎症性肠病(IBD)是一种异质性疾病,其自然史不可预测,会在患者的一生中损害其生活质量。因此,为有效的患者管理提供证据至关重要。
在本病例系列研究中,纳入了198例在2015年10月至2020年5月期间至少三次常规到我们诊所就诊的IBD患者。然后,使用两种基于面板的方法,即多状态模型(MSM)和随机效应有序逻辑回归,来推断IBD的临床病程,包括缓解、轻度、中度至重度和手术状态。
对于溃疡性结肠炎(UC),与男性相比,女性缓解期状况略差,但中度至重度状况较好,且从中度至重度向轻度转变更快(风险比=1.490,95%置信区间:1.02-2.16)。对于克罗恩病(CD),与男性相比,她们缓解期状况较好,但重度状态略差,且从轻度向中度至重度转变更高(风险比=1.221,95%置信区间:0.471-3.22)。口服5-氨基水杨酸(5-ASA)对处于缓解期和/或轻度状态的人疗效较好,但对中度至重度状态的人无效,尤其是在CD患者中(轻度至中度至重度,风险比=1.526,95%置信区间:0.59-3.89)。免疫抑制药物对疾病严重程度较低的患者效果较好,尤其是UC患者(轻度至缓解,风险比=1.258,95%置信区间:0.75-2.09)。
基于面板的方法有潜力应对IBD(UC/CD)不可预测的临床病程。因此,我们强烈建议将我们的研究结果纳入伊朗IBD的常规临床环境,和/或在伊朗及其他地区进行相关研究,以更好地了解IBD的自然史。